Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jul;19(3):147-55.
doi: 10.5863/1551-6776-19.3.147.

Neonatal abstinence syndrome: essentials for the practitioner

Anita Siu  1 , Christine A Robinson  2
Affiliations
Review

Neonatal abstinence syndrome: essentials for the practitioner

Anita Siu et al. J Pediatr Pharmacol Ther. 2014 Jul.

Abstract

The incidence of neonatal abstinence syndrome (NAS) has increased dramatically during the past 15 years, likely due to an increase in antepartum maternal opiate use. Optimal care of these patients is still controversial because of the available published literature lacking sufficient sample size, placebo control, and comparative pharmacologic trials. Primary treatment for NAS consists of opioid replacement therapy with either morphine or methadone. Paregoric and tincture of opium have been abandoned because of relative safety concerns. Buprenorphine is emerging as a treatment option with promising initial experience. Adjunctive agents should be considered for infants failing treatment with opioid monotherapy. Traditionally, phenobarbital has been used as adjunctive therapy; however, results of clonidine as adjunctive therapy for NAS appear to be beneficial. Future directions for research in NAS should include validating a simplified scoring tool, conducting comparative studies, exploring home management options, and optimizing management through pharmacogenomics.

Keywords: abstinence syndrome; buprenorphine; clonidine; methadone; morphine.

PubMed Disclaimer

Comment in

  • J Pediatr Pharmacol Ther. 19:144.

References

    1. Hudak ML, Tan RC, The Committee On Drugs; The Committee On Fetus And Newborn; American Academy of Pediatrics Neonatal drug withdrawal. Pediatrics. 2012;129(2):e540–e560. - PubMed
    1. Results From the 2011 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration; 2013. HHS publication (SMA) 12–4713.
    1. Committee on Health Care for Underserved Women, American Society of Addiction Medicine. ACOG Committee Opinion No. 524: opioid abuse, dependence, and addiction in pregnancy. Obstet Gynecol. 2012;119(5):1070–1076. - PubMed
    1. Patrick SW, Schumacher RE, Benneyworth BD et al. Neonatal abstinence syndrome and associated health care expenditures – United States, 2000–2009. JAMA. 2012;307(18):1934–1940. - PubMed
    1. Jones HE, Kaltenbach K, Heil SH et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363(24):2320–2331. - PMC - PubMed